Furthermore, 2′-O-methyl RNAs have been used in an SMA mouse model to upregulate full-length SMN2 through recruitment of SR proteins for exon 7 splicing following neonatal ICV injection (Baughan et al., 2009). The gene discussed is SMN2; the disease is proximal spinal muscular atrophy.